5.1. Deficiency of CREBH Exacerbates Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). This evidence concerns the gene CREB3L3 and metabolic dysfunction-associated steatotic liver disease.